Provide Pre-approval Single-patient Expanded Access (Compassionate Use) of VYD222 for Patients With Symptomatic COVID-19 Refractory to Other Treatments

N/ANo Longer AvailableNCT06004128

Invivyd, Inc.

Overview

Provide pre-approval single-patient Expanded Access (Compassionate Use) of VYD222 for patients with symptomatic COVID-19 refractory to other treatments.

Study Type

EXPANDED_ACCESS

Conditions

COVID-19

Interventions

VYD222DRUG

Monoclonal antibody

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.